DECREASED CHOLESTEROL-BIOSYNTHESIS IN SITOSTEROLEMIA WITH XANTHOMATOSIS - DIMINISHED MONONUCLEAR LEUKOCYTE-3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE-ACTIVITY AND ENZYME PROTEIN ASSOCIATED WITH INCREASED LOW-DENSITY-LIPOPROTEIN RECEPTOR FUNCTION

We investigated the mechanism for reduced cholesterol biosynthesis in sitosterolemia with xanthomatosis. The conversion of acetate to cholesterol and total and active hydroxymethylglutaryl (HMG) coenzyme A (CoA) reductase activities, enzyme protein mass, and catalytic efficiency were related to low-density lipoprotein (LDL) receptor function in freshly isolated mononuclear leukocytes collected at 9 am after a 12-hour fast from two affected sisters and 12 control subjects. Active HMG-CoA reductase activity was determined in mononuclear leukocyte microsomes prepared and assayed in the presence of sodium fluoride, while total HMG-CoA reductase activity was determined in the absence of the phosphatase inhibitor. Enzyme protein was assayed using rabbit polyclonal anti-rat liver microsomal HMG-CoA reductase serum. The rates at which [14C]acetate was transformed to cholesterol by sitosterolemic mononuclear leukocytes were decreased 29% and 41%, respectively, compared with the mean value for mononuclear leukocytes from 12 control subjects. Similarly, total HMG-CoA reductase activities were 71% and 68% lower in sitosterolemic mononuclear leukocyte microsomes and were associated with 62% and 65% less enzyme protein than the mean for the control microsomal preparations. This marked decrease in HMG-CoA reductase protein mass in sitosterolemic microsomes was partially compensated for by an increase in the proportion of active enzyme. Sitosterolemic plasma and mononuclear leukocyte cholesterol concentrations were not significantly different from control values, although total sterol levels were increased about 20% because of abundant plant sterols. In contrast, receptor-mediated LDL degradation by sitosterolemic mononuclear leukocytes was increased 50% over control. Our findings demonstrate reduced cholesterol formation in sitosterolemic mononuclear leukocytes that results from a deficiency of HMG-CoA reductase, the rate-controlling enzyme for cholesterol biosynthesis. Low cholesterol synthesis was partially offset by increased proportion of active enzyme and by enhanced cellular sterol intake via the receptor-mediated LDL pathway. Increased sitosterol absorption and tissue pools also compensate for reduced cholesterol production in this disease. © 1990.